MPM Oncology Impact Management »

Twist Bioscience Corp shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Twist Bioscience Corp (TWST) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Twist Bioscience Corp

Tip: Access up to 7 years of quarterly data

All positions including Twist Bioscience Corp held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Twist Bioscience Corp by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $10M 261k 39.26
2024-12-31 $12M 268k 46.47
2024-09-30 $13M 295k 45.18

More positions owned by MPM Oncology Impact Management

Madrigal Pharmaceuticals Common (MDGL)
Cullinan Therapeutics Common (CGEM)
Avidity Biosciences Common (RNA)
Trevi Therapeutics Common (TRVI)
Edgewise Therapeutics Common (EWTX)
PTC Therapeutics Common (PTCT)
Zai Lab Adr (ZLAB)
Syndax Pharmaceuticals Common (SNDX)
Oric Pharmaceuticals Common (ORIC)
Tarsus Pharmaceuticals Common (TARS)
Xenon Pharmaceuticals Common (XENE)
Stoke Therapeutics Common (STOK)
Dyne Therapeutics Common (DYN)
Compass Therapeutics Common (CMPX)
Alkermes Common (ALKS)

View all positions for MPM Oncology Impact Management

Top funds holding Twist Bioscience Corp

ARK Investment Management
Artisan Partners Limited Partnership
BlackRock
Vanguard Group
William Blair Investment Management
Edgepoint Investment
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Soleus Capital Management
Invesco
Millennium Management
Goldman Sachs Group
Thrivent Financial for Lutherans
Geode Capital Management

View all funds holding Twist Bioscience Corp